Head in the Clouds
Organ-to-cloud technology is here – and it has its sights set on glaucoma. Offering a stream of objective, uncompromised data, it could revolutionize the glaucoma space… But for it to work, we need to rethink the way we assess therapy effectiveness in our current treatment paradigm.
Ariel Cao | | Longer Read
When was the last time you bought a CD? I’m guessing it was a long time ago. Nowadays, you probably pay nine dollars a month for a music streaming service that lets you listen to whatever song you like, whenever you like, on whatever device you like – amazingly, with minimum fuss.
Given the choice, I doubt you would go back to CDs. Why? Because streaming makes sense. We live in an era of constant connection, where we can access the information we need anytime, from anywhere. Real-time event updates mean we can predict and plan for change. Yet, somehow, this does not translate to the medical field. An ophthalmologist treating a progressive disease like glaucoma can’t be anything but reactive; critical data on a patient’s disease state is only collected during sporadic office visits, yielding only a few single data points to interpret past trends and assess long-term risk – often with harmful results.
Read the full article now
Log in or register to read this article in full and gain access to The Ophthalmologist’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Ophthalmologist magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.